United States (US) Antimicrobial Resistance Diagnostics Market (2025-2031) | Forecast, Analysis, Companies, Industry, Size & Revenue, Trends, Outlook, Value, Segmentation, Share, Growth, Competitive Landscape

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 United States (US) Country Macro Economic Indicators

3.2 United States (US) Antimicrobial Resistance Diagnostics Market Revenues & Volume, 2021 & 2031F

3.3 United States (US) Antimicrobial Resistance Diagnostics Market - Industry Life Cycle

3.4 United States (US) Antimicrobial Resistance Diagnostics Market - Porter's Five Forces

3.5 United States (US) Antimicrobial Resistance Diagnostics Market Revenues & Volume Share, By Technology, 2021 & 2031F

3.6 United States (US) Antimicrobial Resistance Diagnostics Market Revenues & Volume Share, By Pathogen, 2021 & 2031F

3.7 United States (US) Antimicrobial Resistance Diagnostics Market Revenues & Volume Share, By End-user, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of antibiotic-resistant infections in the US

4.2.2 Growing awareness among healthcare professionals and patients about the importance of antimicrobial resistance diagnostics

4.2.3 Technological advancements leading to the development of more accurate and rapid diagnostic tools

4.3 Market Restraints

4.3.1 High costs associated with antimicrobial resistance diagnostics tests

4.3.2 Limited access to advanced diagnostic technologies in certain healthcare facilities

4.3.3 Stringent regulatory requirements for approval of new diagnostic tests

6.1 United States (US) Antimicrobial Resistance Diagnostics Market, By Technology

6.1.1 Overview and Analysis

6.1.2 United States (US) Antimicrobial Resistance Diagnostics Market Revenues & Volume, By Technology, 2021- 2031F

6.1.3 United States (US) Antimicrobial Resistance Diagnostics Market Revenues & Volume, By Microbiology Culture, 2021- 2031F

6.1.4 United States (US) Antimicrobial Resistance Diagnostics Market Revenues & Volume, By Immunoassay, 2021- 2031F

6.1.5 United States (US) Antimicrobial Resistance Diagnostics Market Revenues & Volume, By PCR, 2021- 2031F

6.1.6 United States (US) Antimicrobial Resistance Diagnostics Market Revenues & Volume, By NGS, 2021- 2031F

6.1.7 United States (US) Antimicrobial Resistance Diagnostics Market Revenues & Volume, By Mass Spectrometry, 2021- 2031F

6.1.8 United States (US) Antimicrobial Resistance Diagnostics Market Revenues & Volume, By Rapid & Point of Care, 2021- 2031F

6.2 United States (US) Antimicrobial Resistance Diagnostics Market, By Pathogen

6.2.1 Overview and Analysis

6.2.2 United States (US) Antimicrobial Resistance Diagnostics Market Revenues & Volume, By Drug Resistant Streptococcus Pneumoniae (DRSP), 2021- 2031F

6.2.3 United States (US) Antimicrobial Resistance Diagnostics Market Revenues & Volume, By Drug Resistant Campylobacter (DRC), 2021- 2031F

6.2.4 United States (US) Antimicrobial Resistance Diagnostics Market Revenues & Volume, By Clostridium Difficile (CD), 2021- 2031F

6.2.5 United States (US) Antimicrobial Resistance Diagnostics Market Revenues & Volume, By Methicillin Resistant Staphylococcus Aureus (MRSA), 2021- 2031F

6.2.6 United States (US) Antimicrobial Resistance Diagnostics Market Revenues & Volume, By Drug Resistant Neisseria Gonorrhoeae (DRNG), 2021- 2031F

6.2.7 United States (US) Antimicrobial Resistance Diagnostics Market Revenues & Volume, By Drug Resistant Salmonella (DRNTS), 2021- 2031F

6.3 United States (US) Antimicrobial Resistance Diagnostics Market, By End-user

6.3.1 Overview and Analysis

6.3.2 United States (US) Antimicrobial Resistance Diagnostics Market Revenues & Volume, By Hospitals, 2021- 2031F

6.3.3 United States (US) Antimicrobial Resistance Diagnostics Market Revenues & Volume, By Diagnostic Laboratories, 2021- 2031F

6.3.4 United States (US) Antimicrobial Resistance Diagnostics Market Revenues & Volume, By Pharmaceutical & Biotechnology Companies, 2021- 2031F

6.3.5 United States (US) Antimicrobial Resistance Diagnostics Market Revenues & Volume, By Others, 2021- 2031F

7.1 United States (US) Antimicrobial Resistance Diagnostics Market Export to Major Countries

7.2 United States (US) Antimicrobial Resistance Diagnostics Market Imports from Major Countries

8.1 Percentage increase in the adoption rate of antimicrobial resistance diagnostics in US healthcare facilities

8.2 Number of research and development partnerships between diagnostic companies and healthcare institutions focused on antimicrobial resistance

8.3 Average turnaround time for antimicrobial resistance diagnostic test results in the US

8.4 Percentage of healthcare professionals trained in the proper use and interpretation of antimicrobial resistance diagnostic tests

9.1 United States (US) Antimicrobial Resistance Diagnostics Market Opportunity Assessment, By Technology, 2021 & 2031F

9.2 United States (US) Antimicrobial Resistance Diagnostics Market Opportunity Assessment, By Pathogen, 2021 & 2031F

9.3 United States (US) Antimicrobial Resistance Diagnostics Market Opportunity Assessment, By End-user, 2021 & 2031F

10.1 United States (US) Antimicrobial Resistance Diagnostics Market Revenue Share, By Companies, 2024

10.2 United States (US) Antimicrobial Resistance Diagnostics Market Competitive Benchmarking, By Operating and Technical Parameters